Form 4 for OKYO OKYO Pharma Ltd
Accepted 2026-06-10 16:30:22 ET · period of report 2026-06-08 · accession 0001493152-26-028117 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-06-10 16:30 | 2026-06-08 | OKYO | CERRONE GABRIELE M | Dir, 10% | A - Grant | $1.72 | +300.0K | 10.83M | +3% | +$516.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2026-06-08 | A | A | 300,000 | $1.72 | 10,826,416 | I Via Panetta Partners Limited | — | — |